Phase I/II Study of Neoadjuvant Weekly Docetaxel and Mitoxantrone Prior to Prostatectomy in Patients With High Risk Localized Prostate Cancer.
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Docetaxel; Mitoxantrone
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 28 Apr 2017 Biomarkers information updated
- 28 Apr 2011 Planned end date (May 2010) added as reported by ClinicalTrials.gov.
- 25 Oct 2007 Status changed from suspended to in progress.